Pages that link to "Q39642381"
Jump to navigation
Jump to search
The following pages link to Controlled treatment trials in the irritable bowel syndrome: a critique. (Q39642381):
Displaying 50 items.
- Psychological treatments for the management of irritable bowel syndrome (Q24241516) (← links)
- Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. (Q24534461) (← links)
- Functional Somatic Syndromes: Emerging Biomedical Models and Traditional Chinese Medicine (Q24799124) (← links)
- Evaluation of the Birmingham IBS symptom questionnaire (Q33354600) (← links)
- Effects of Two Natural Medicine Formulations on Irritable Bowel Syndrome Symptoms: A Pilot Study (Q33448190) (← links)
- Therapeutic approach to the patient with irritable bowel syndrome (Q33788426) (← links)
- Entry criteria for drug trials of irritable bowel syndrome (Q33788442) (← links)
- Inclusion and exclusion criteria of importance in irritable bowel syndrome trials (Q33788448) (← links)
- The relationship between psychosocial parameters and outcome in irritable bowel syndrome (Q33788458) (← links)
- Likely impacts of recruitment site and methodology on characteristics of enrolled patient population: irritable bowel syndrome clinical trial design (Q33788469) (← links)
- Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials (Q33788475) (← links)
- Irritable bowel syndrome clinical trial design: future needs (Q33788481) (← links)
- Long-term outcome from tricyclic antidepressant treatment of functional chest pain (Q33814182) (← links)
- Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial (Q33896354) (← links)
- New concepts of irritable bowel syndrome (Q34027875) (← links)
- New therapies for functional bowel diseases (Q34040358) (← links)
- Placebo responses in patients with gastrointestinal disorders (Q34098616) (← links)
- High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). (Q34144982) (← links)
- Irritable bowel syndrome: new agents targeting serotonin receptor subtypes (Q34212885) (← links)
- Health status and management of chronic non-specific abdominal complaints in general practice (Q34218473) (← links)
- Quality of life in irritable bowel syndrome (Q34309891) (← links)
- Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders (Q34375132) (← links)
- Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia (Q34379049) (← links)
- Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial (Q34391589) (← links)
- Relation between hysterectomy and the irritable bowel: a prospective study (Q34395465) (← links)
- Pathophysiology and management of irritable bowel syndrome (Q34479610) (← links)
- Guidelines on the irritable bowel syndrome: mechanisms and practical management. (Q34626602) (← links)
- Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study (Q34735920) (← links)
- Irritable bowel syndrome: evaluation and treatment (Q35176961) (← links)
- A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. (Q35200499) (← links)
- Evaluation of drug treatment in irritable bowel syndrome (Q35216829) (← links)
- Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome (Q35216885) (← links)
- Drug treatment of the irritable bowel syndrome (Q35336680) (← links)
- Change in functional bowel symptoms after prostatectomy: a case-control study (Q35544628) (← links)
- Functional bowel disorders and irritable bowel syndrome in Europe (Q35553251) (← links)
- British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome (Q35579339) (← links)
- Tegaserod and IBS: a perfect match? (Q35595588) (← links)
- Benefit-risk assessment of tegaserod in irritable bowel syndrome (Q35683216) (← links)
- Ranking of symptoms by patients with the irritable bowel syndrome (Q35718213) (← links)
- Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study (Q36122008) (← links)
- Functional diarrhea (Q36259657) (← links)
- Irritable bowel syndrome. Strategy for the family physician (Q36653122) (← links)
- Current views on the aetiology and management of the irritable bowel syndrome (Q36682197) (← links)
- Fortnightly Review: Irritable bowel, irritable body, or irritable brain? (Q36901988) (← links)
- Updates on treatment of irritable bowel syndrome (Q37156627) (← links)
- Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium (Q37492917) (← links)
- Stress reactivity in traditional Chinese medicine-based subgroups of patients with irritable bowel syndrome (Q37715490) (← links)
- Review article: endpoints used in functional dyspepsia drug therapy trials (Q37827564) (← links)
- Placebo effects and their determinants in gastrointestinal disorders (Q38551120) (← links)
- Psychological treatments of the irritable bowel syndrome: a review (Q38740138) (← links)